PELOTON INTE.A DL-_000025
Commented by Juliane Zielonka on February 17th, 2022 | 12:10 CET
Peloton, Diamcor, Bayer - Trust, tangibles and expertise
Peloton gets in shape with streamlining just like its existing customers. 90% of early adopters remain loyal to the Company. Rough diamonds achieve new record prices, Diamcor profits, and so do its investors. Bayer comes up trumps in the agricultural business with innovative solutions for corn cultivation. In the upcoming market phase, investors want to be prepared. Investing in price-setters that take advantage of strong inflation makes sense. We take a look at three investment opportunities.
Read
Commented by Nico Popp on February 10th, 2022 | 11:14 CET
BioNTech, Cardiol Therapeutics, Peloton: Future check on pandemic stocks
There are pandemic stocks that are already out today. But there are also pandemic stocks that are only now taking off operationally. We take a look at three stocks and do a future check: Where has the pandemic only provided the initial spark, and where is the hype irretrievably over?
Read
Commented by Carsten Mainitz on February 8th, 2022 | 13:53 CET
Peloton, Aspermont, Netflix - Sustainable digital models
The digital transformation of society and the economy started before Corona but was significantly accelerated by the pandemic. Whether across industries in business, sports or schools, digital business models are the future. If companies resist, they will likely soon be a thing of the past. On the other hand, there are winners emerging from the transformation stronger than before.
Read
Commented by Nico Popp on January 27th, 2022 | 10:13 CET
Valneva, XPhyto, Peloton Interactive: What is next for pandemic stocks?
The pandemic is entering a new phase. Although incidences are rising towards the 1,000 mark, the population is largely relaxing. In the meantime, almost everyone knows someone who has fallen ill; as a rule, the scare is over quickly for those who have been vaccinated. In this article, we look at what this means for the stock market.
Read